Navigation Links
New Guidelines To Rehabilitate Drug Offenders

Recently, new guidelines and principles were issued to rehabilitate drug offenders. The 13 principles are contained in a report prepared by the National Institute// on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH). The report, which is titled, Principles of Drug Abuse Treatment for Criminal Justice Populations, uses some of the work conducted by University of Kentucky Researchers Michele Staton-Tindall, Assistant Professor in the Department of Behavioral Science and Center on Drug and Alcohol Research (CDAR) and Carl Leukefeld, Professor of Behavioral Science and Director of CDAR.

Findings from Staton-Tindall's 2003 Kentucky study were used to profile the substance use, mental health problems, health problems and treatment history of incarcerated women. These findings point out the unique issues of women in criminal justice settings. The article is one of only wo peer-reviewed articles cited in the entire NIH report.

Staton-Tindall and Leukefeld's research is part of the NIDA/NIH-funded Central States Criminal Justice Drug Abuse Treatment Research Systems (CJ-DATS) Center in Lexington. It is one of nine such centers in the U.S. The CJ-DATS Center studies drug abuse interventions in the criminal justice system. The goal of the research is to develop, implement, and test interventions to reduce recidivism, drug abuse and crime.

It is estimated that 70 percent of people incarcerated in state prisons and local jails, in Kentucky and elsewhere, have at some point been regular drug users – compared to approximately 9 percent of the general population. Despite these figures, only about 20 percent of incarcerated offenders receive any rehabilitation treatment. Lawmakers and taxpayers have long been loathe to approve extensive drug abuse treatment programs, fearing financial costs. Drug abuse costs communities every day, in the form of prison expenses, court costs, property damage, violent crimes, emergency room
'"/>




Page: 1 2

Related medicine news :

1. New CPR Guidelines issued by Heart Association
2. New Guidelines Found To Benefit Cardiovascular Treatment
3. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
4. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
5. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
6. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
7. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
8. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
9. Guidelines for treatment of juvenile idiopathic arthritis formulated
10. Guidelines For Better Management Of Obsessive-Compulsive Disorder
11. Poultry Workers To Adopt Anti-Flu Guidelines
Post Your Comments:
Breaking Medicine Technology:Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 1Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 2Valeant Grants Schering Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal 47437 3Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 1Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 2Rigels R788 Evaluated in Phase 2 Trial in Multiple Cancers 47432 3SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 1SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 2SAFC Pharmas St Louis HPAPI Conjugates Facility Receives SafeBridge Certification 47429 3